FMP
Global WholeHealth Partners Corporation
GWHP
PNK
Inactive Equity
Global WholeHealth Partners Corporation develops and markets various in-vitro diagnostic test kits in the United States. The company offers rapid diagnostic tests, such as the CoVid-19 test, whole blood Ebola test, whole blood Zika test, whole blood rapid TB test, and various other tests for over-the-counter or consumer-use, as well as for point-of-care, which includes hospitals, physicians' offices, and medical clinics. It provides tests for various diseases, such as Ebola, zika, dengue, malaria, influenza, tuberculosis, coronaviruses, and other vector-borne diseases. Global WholeHealth Partners Corporation was incorporated in 2013 and is based in San Clemente, California.
0.00001 USD
-0.0001 (-1000%)
Valuation Date:
Sep 6, 2024 4:00 PM
Share Price on Valuation Date
$0
Stock Beta
-11.467
Shares Outstanding
131287000